Skip to main content

Table 2 Average HBV DNA and ALT levels before and after treatment

From: Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission

  Group A Group B Group C P
Sujects, n 62 61 65  
HBV DNA viral load, log10 copies/ml
 Before treatment 7.79 ± 0.22 7.75 ± 0.19 7.74 ± 0.22 0.373
 Before delivery 0.51 ± 1.44 0.49 ± 1.26 7.64 ± 0.24 <0.001
 Postpartum 12 weeks 0.38 ± 1.12 0.35 ± 1.28 7.85 ± 0.27 <0.001
ALT levels, IU/mL
 Before treatment 125.3 ± 57.6 132.3 ± 52.9 128.5 ± 48.7 0.766
 Before delivery 63.8 ± 15.6 59.5 ± 13.4 112.7 ± 24.1 <0.001
 Postpartum 12 weeks 48.9 ± 18.2 51.3 ± 20.1 84.1 ± 32.5 <0.001